Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06238180

Personalised Real-time Interoperable Sepsis Monitoring (PRISM)

Prediction of Sepsis in Patients Undergoing Abdominal Surgery: A Prospective, Observational Clinical Study

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Aisthesis Medical P.C. · Industry
Sex
All
Age
18 Years – 120 Years
Healthy volunteers

Summary

The goal of this prospective observational study is to develop and utilize an Artificial Intelligence (AI) model for the prediction of postoperative sepsis in patients undergoing abdominal surgery. The main questions it aims to answer are: 1. Can a remote AI-driven monitoring system accurately predict sepsis risk in postoperative patients? 2. How effectively can this system integrate and analyze multimodal data for early sepsis detection in the surgical ward? Participants are equipped with non-invasive PPG-based wearable devices to continuously monitor vital signs and collect high-quality clinical data. This data, along with demographic and laboratory information from the Electronic Health Record (EHR) of the hospital, are used for AI model development and validation.

Conditions

Interventions

TypeNameDescription
DEVICEPRISM ToolThe intervention in this study involves an AI-driven clinical decision-support system, PRISM Tool, designed for the early prediction of sepsis in patients undergoing abdominal surgery. PRISM Tool integrates data from PPG-based wearable wireless devices that monitor vital signs, electronic health records, and laboratory tests. The AI model analyzes this multimodal data to proactively identify signs of sepsis providing an early warning score to clinicians. The distinguishing feature of this intervention is its use of real-time data and advanced AI analytics to enhance early sepsis detection, aiming to improve patient outcomes in postoperative care.

Timeline

Start date
2023-11-29
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2024-02-02
Last updated
2026-04-09

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT06238180. Inclusion in this directory is not an endorsement.